Yep I reckon you are right there musoman.
A good portion of their activities a VERY much focussed on problem wound care. The have the size and reach that the TIS needs to capture a good bite of this market. They have amongst the most globally to gain should they align with and market Vitrogro. (even though it may make a bunch of their current products obsolete) Accordingly they also have a lot to lose should it go to a competitor.
Further, on rummaging about on the S@N site there is a lot of the same language used in talking about wound care that TIS use in thier presentations. I was going to copy and past a whole bunch of potential linkages between the two companies but its best if the Tissarians just have a look for them selves
checkit
Snapping
http://global.smith-nephew.com/master/wound_management_1217.htm
- Forums
- ASX - By Stock
- TIS
- world-first $100 million health resrch centre
world-first $100 million health resrch centre, page-3
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TIS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online